Zoledronic acid, 99mTc
Stock
Radiopharmaceutical kit
Composition
Zoledronic acid 1.5 mg/ Stannous chloride anhydrous 0.33 mg
Indications
For detection and identification of lytic, mixed and blast metastases in the skeleton in malignant tumors of different genesis and extension
Dosing
1 vial per 5 patients
Storage, Shelf life
2-10°С, 1 year